Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (HK:2252)

HKEX:2252

2252

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding HK:2252?

Track your performance easily

Link Broker

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H (2252) Stock Price & Analysis

0 Followers

2252 Stock Chart & Stats

Advanced Chart >

Day’s RangeHK$0 - HK$0

52-Week RangeHK$6.03 - HK$21.35

Previous CloseHK$6.97

Volume242.50K

Average Volume (3M)1.19M

Market Cap

HK$6.77B

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta1.35

Next Earnings

Mar 26, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.85

Shares OutstandingN/A

10 Day Avg. Volume1,355,538

30 Day Avg. Volume1,193,635

Standard Deviation0.21

R-Squared0.09

Alpha-0.03

Financial Highlights & Ratios

Price to Book (P/B)0.00

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$9.50

Price Target Upside36.30% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H News

PremiumCompany Announcements

Shanghai MedBot Reports Halved Net Loss, Revenue Growth

23d ago

2252

PremiumCompany Announcements

Shanghai MicroPort MedBot Announces Key Board Meeting

1M ago

2252

PremiumCompany Announcements

Shanghai MicroPort Announces Corporate Reshuffle

1M ago

2252

PremiumCompany Announcements

Shanghai MicroPort MedBot’s EGM Secures Key Approvals

2M ago

2252

PremiumCompany Announcements

MicroPort MedBot Announces Board Structure

2M ago

2252

PremiumCompany Announcements

Shanghai MicroPort MedBot Completes Share Placement

3M ago

2252

PremiumCompany Announcements

MicroPort MedBot Expects Major Revenue Growth

3M ago

2252

PremiumCompany Announcements

Shanghai MicroPort MedBot Announces EGM Details

3M ago

2252

See More HK:2252 News >

Options Prices

Currently, No data available

---

Ownership Overview

0.00%

Insiders

0.77% Mutual Funds

1.91% Other Institutional Investors

97.32% Public Companies and

Individual Investors

Detailed Ownership Overview >

2252 FAQ

What was Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s price range in the past 12 months?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H lowest stock price was HK$6.03 and its highest was HK$21.35 in the past 12 months.

What is Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s market cap?

Currently, no data Available

When is Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s upcoming earnings report date?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s upcoming earnings report date is Mar 26, 2025 which is in 187 days.

How were Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s earnings last quarter?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H released its earnings results on Aug 28, 2024. The company reported -HK$0.319 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.319.

Is Shanghai MicroPort MedBot (Group) Co., Ltd. Class H overvalued?

According to Wall Street analysts Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Shanghai MicroPort MedBot (Group) Co., Ltd. Class H pay dividends?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H does not currently pay dividends.

What is Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s EPS estimate?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shanghai MicroPort MedBot (Group) Co., Ltd. Class H have?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H has 964,894,300 shares outstanding.

What happened to Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s price movement after its last earnings report?

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H reported an EPS of -HK$0.319 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.391%.

Which hedge fund is a major shareholder of Shanghai MicroPort MedBot (Group) Co., Ltd. Class H?

Currently, no hedge funds are holding shares in HK:2252

---

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H Stock Smart Score

Unlock Smart Score

Analyst Consensus

Moderate Buy

Average Price Target:
HK$9.50 (36.30% Upside)

Fundamentals

Return on Equity

-122.62%

Trailing 12-Months

Asset Growth

-35.87%

Trailing 12-Months

Top Smart Score Stocks >

2252 Stock 12 Month Forecast

Average Price Target

HK$9.50

▲(36.30% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"HK$6","23":"HK$23","10.25":"HK$10.25","14.5":"HK$14.5","18.75":"HK$18.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$9.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$9.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,10.25,14.5,18.75,23],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"Feb<br/>2024","9":"Apr<br/>2024","12":"Sep<br/>2024","25":"Sep<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.38,7.543076923076923,7.706153846153846,7.869230769230769,8.032307692307691,8.195384615384615,8.358461538461539,8.521538461538462,8.684615384615384,8.847692307692308,9.010769230769231,9.173846153846155,9.336923076923076,{"y":9.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.38,7.543076923076923,7.706153846153846,7.869230769230769,8.032307692307691,8.195384615384615,8.358461538461539,8.521538461538462,8.684615384615384,8.847692307692308,9.010769230769231,9.173846153846155,9.336923076923076,{"y":9.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.38,7.543076923076923,7.706153846153846,7.869230769230769,8.032307692307691,8.195384615384615,8.358461538461539,8.521538461538462,8.684615384615384,8.847692307692308,9.010769230769231,9.173846153846155,9.336923076923076,{"y":9.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.5,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.64,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.1,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.36,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.58,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.9,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":10.48,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.84,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12.72,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":12.56,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.4,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.02,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.38,"date":1726185600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >

Technical Analysis

Similar Stocks

Suzhou Basecare Medical Corp. Ltd. Class H

―

9966

Alphamab Oncology

―

2400

XD, Inc.

―

Compare HK:2252 Stocks >

Best Analysts Covering 2252

1 Year

Chen ChenUBS

1 Year Success Rate

1/2 ratings generated profit

1 Year Average Return

-15.85%

reiterated a buy rating 9 days ago

Copying Chen Chen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -15.85% per trade.

Best Analyst Covering >

Popular Stocks

---

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing